Bioregenx (BRGX) Return on Equity ROE from the first quarter 2026 to first quarter 2025 and annually, average high and low, overall ranking from Mar 31 2026 to Mar 31 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
BIOREGENX, INC.  (OTC: BRGX)

Bioregenx's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Bioregenx in the first quarter 2026?
Due to the lack of equity, it was not possible to calculate Bioregenx, Inc.'s return on equity (ROE) in its first quarter 2026

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Equity Change - - - - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -1 -2 -21 -22 -23
Return On Equity (TTM) - - - -2923.05 % -434.01 %
BRGX's Total Ranking # # # # #
Equity (TTM) in Millions -5 -5 -4 -4 -4
Seq. Equity Change - - - - -
Seq. Net Income Change - - - - -

Back to BRGX Management Effectiveness >> BRGX's 5 Years Annual ROE >> Compare BRGX ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Equity Statistics
High Average Low
0 %
0 %
0 %
 





BRGX Annual Return On Equity (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2021)
2022
Total Equity in Millions -5 -3 -2 0 0
Y / Y Equity Change - - - - -
Net Income in Millions -2 -23 -4 0 0
Y / Y Net Income Change - - - - -
Return On Equity - - - - -

Back to BRGX Management Effectiveness >> BRGX's 5 Years Annual ROE >> Compare BRGX ROE to its Competitors




More Return On Equity Ratios
Internet Services & Social Media Industry Roe Trends and Statistics
Technology Sector Return On Equity Statistics
BRGX's' Return on Equity at Yahoo Finance
BRGX's Roe Ratio versus Internet Services & Social Media Industry, Technology Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for BRGX's Competitors
Subscribers only: Roe for Bioregenx's Suppliers
Subscribers only: Return On Equity for BRGX's Customers




Companies with similar Return On Equity at Mar 31 2026, within Technology Sector ROE
Future Vision Ii Acquisition Corp   83.83 %
Manhattan Associates Inc   78.22 %
Pagerduty Inc   76.27 %
Skywater Technology Inc   74.84 %
Automatic Data Processing Inc   69.25 %
Fdctech Inc   68.14 %
Data Storage Corporation  66.26 %
Adobe Inc   62.31 %
Oracle Corporation  61.37 %
Jabil Inc  58.76 %
Everquote Inc   53.39 %
Pegasystems Inc   50.21 %
Light and Wonder Inc   49.67 %
Autodesk Inc   49.42 %
Lumentum Holdings Inc   48.06 %
Ncr Atleos Corporation  47.55 %
Celestica Inc   47.33 %
Egain Corporation  45.68 %
Sandisk Corporation  43.35 %
Vertiv Holdings Co  42.06 %
Cargurus Inc   41.93 %
Qualcomm Inc  40.96 %
Micron Technology Inc   40.84 %
Applied Materials Inc  40.40 %
Gen Digital Inc   40.12 %
Credo Technology Group Holding Ltd  39.25 %
Alphabet Inc   38.98 %
Neonode Inc   38.45 %
Innodata inc   37.50 %
Ondas Inc   37.42 %

Date modified: 2026-09-12T06:28:47+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.